Natasha Appelman-dijkstra MD, PhD

Professor Natasha M. Appelman-Dijkstra is an internist-endocrinologist at the Leiden University Medical Center. Since September 2022, she has been the director of the Academic Residency Program in Internal Medicine of the LUMC and its surrounding hospitals. Furthermore, she leads the Bone Center of the LUMC, a (inter)national Reference Center for Bone and Mineral disorders, participating in the European Reference Networks for Rare Bone Disorders (ERN BOND) and the Reference Network for Rare Endocrine Conditions (Endo-ERN).

Natasha received a Young Investigators award from the American Society for Bone and Mineral Research in 2014, a Young Investigators award in 2018 from the Rare Bone Disease Alliance, and the Ian T Boyle Award of the European Calcified Tissue Society in 2022, an award presented to young scientists who have made significant progress and contributions to the field of bone and calcified tissue. Within Europe, she coordinates the European Registries for Rare Endocrine and Bone conditions (EuRREB, www.eurreb.eu) and coordinates the Registries' work packages within ERN BOND and Endo-ERN, 2 EU4Health projects. Professor Natasha M. Appleelman-Dijkstra serves as a medical advisor for many patient associations, is part of the Dutch national indication committee for Burosumab, and was one of the main authors of the Dutch Osteoporosis guideline.